see
editori
commentari
ruuskanen
page
background
role
viral
infect
etiolog
sever
communityacquir
pneumonia
scap
prospect
evalu
universitylevel
intens
care
unit
method
clinic
data
microbiolog
test
assess
blood
cultur
urin
pneumococc
legionella
antigen
mycoplasma
pneumonia
chlamydia
pneumonia
antibodi
pair
serum
respiratori
viru
detect
multiplex
realtim
polymeras
chain
reaction
pcr
nasopharyng
swab
lower
tracheal
specimen
via
intub
tube
result
mechan
ventil
scap
patient
men
women
median
age
year
etiolog
identifi
case
pure
bacteri
infect
probabl
pure
viral
infect
mix
bacterialvir
infect
result
viral
etiolog
patient
virus
detect
bronchial
specimen
nasopharyng
swab
rhinoviru
case
adenoviru
case
common
viral
find
bacterialvir
etiolog
group
highest
peak
creactiv
protein
level
median
percentil
p
wherea
patient
probabl
viral
etiolog
lowest
peak
procalcitonin
level
percentil
clinic
characterist
pure
bacteri
mix
bacterialvir
etiolog
compar
hospit
stay
longest
among
bacteri
group
vs
day
p
conclus
viral
find
demonstr
almost
half
scap
patient
clinic
characterist
similar
pure
bacteri
mix
bacterialvir
infect
group
frequenc
viral
detect
depend
avail
pcr
techniqu
lower
respiratori
specimen
communityacquir
pneumonia
cap
complex
diseas
twenti
percent
patient
cap
hospit
onetenth
inpati
sever
cap
scap
requir
treatment
intens
care
unit
icu
typic
requir
ventilatori
support
septic
shock
treatment
bacteri
etiolog
cap
scap
well
defin
common
bacterium
affect
patient
group
streptococcu
pneumonia
mycoplasma
pneumonia
chlamydia
pneumonia
predominantli
found
among
young
cap
patient
legionella
pneumophila
compris
import
caus
cap
worldwid
approxim
million
viral
cap
case
occur
annual
half
case
among
adult
new
molecular
diagnost
assay
polymeras
chain
reaction
pcr
test
introduc
past
year
increas
abil
detect
respiratori
virus
accord
publish
studi
virus
account
cap
case
among
adult
best
author
knowledg
publish
studi
focus
viral
etiolog
scap
purpos
prospect
studi
evalu
presenc
clinic
cours
viral
infect
mechan
ventil
scap
patient
use
multiplex
pcr
methodolog
studi
popul
consist
cohort
scap
patient
admit
mix
icu
tertiari
referr
univers
hospit
june
may
purpos
studi
sever
cap
defin
acut
lower
respiratori
tract
infect
fever
hypothermia
cough
dyspnea
acquir
outsid
hospit
presenc
pneumonia
confirm
chest
radiographi
demonstr
new
pulmonari
infiltr
patient
fulfil
criteria
sever
sepsi
adult
patient
age
year
scap
expect
requir
intens
care
treatment
hour
start
mechan
ventil
first
hour
follow
icu
admiss
includ
studi
patient
life
expect
hour
due
sever
diseas
whose
hospit
stay
day
prior
icu
admiss
exclud
hospit
ethic
committe
approv
studi
protocol
written
inform
consent
request
patient
next
kin
follow
data
obtain
age
sex
bodi
mass
index
preexist
comorbid
chronic
pulmonari
diseas
coronari
arteri
vascular
diseas
diabet
alcohol
smoke
immunosuppress
medic
malign
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
new
simplifi
acut
physiolog
score
sap
ii
daili
sequenti
organ
failur
assess
sofa
score
laboratori
data
also
obtain
daili
creactiv
protein
crp
level
procalcitonin
pct
siemen
centaur
xp
advia
centaur
brahm
pct
white
cell
count
platelet
count
lactat
level
creatinin
level
biochem
paramet
radiolog
clinic
find
includ
antibiot
treatment
prior
hospit
icu
admiss
blood
cultur
prior
icu
stay
septic
shock
upon
admiss
well
need
mechan
ventil
record
pulmonari
complic
pleural
fluid
empyema
alveolar
edema
regist
sum
pneumonia
sever
index
psi
confus
urea
respiratori
rate
blood
pressur
score
infecti
diseas
societi
americaamerican
thorac
societi
idasat
major
criteria
need
invas
mechan
ventil
septic
shock
requir
vasopressor
noradrenalin
infus
minor
criteria
scap
also
calcul
length
icu
hospit
stay
icu
hospit
mortal
analyz
definit
acut
kidney
injuri
base
renal
sofa
score
sofa
serum
creatinin
level
daili
diuresi
mlday
sofa
serum
creatinin
level
daili
diuresi
mlday
icu
stay
septic
shock
defin
accord
standard
criteria
first
hour
icu
admiss
least
blood
sampl
obtain
patient
blood
cultur
use
automat
blood
cultur
monitor
system
bact
alert
tracheobronchi
aspir
respiratori
bacteri
diagnost
urin
sampl
binaxnow
pneumonia
urin
antigen
l
pneumophila
antigen
detect
binaxnow
aler
scarborough
pleural
fluid
cultur
pleural
punctur
drainag
requir
pair
serum
sampl
serolog
detect
pneumonia
c
pneumonia
also
obtain
upon
icu
admiss
hospit
discharg
bronchial
specimen
underw
gram
stain
purul
sampl
leukocyteepitheli
cell
ratio
consid
signific
find
yield
differ
bacteria
pleural
fluid
bronchoalveolar
lavag
bal
sampl
stain
quantit
cultur
bacteri
pathogen
fungi
addit
bal
sampl
subject
papanicolau
maygrunwaldgiemsa
stain
obtain
cellular
differenti
count
well
gomori
methenamin
silver
stain
pneumocysti
jirovecii
mycobacteria
detect
stain
cultur
pcr
microorgan
consid
definit
caus
scap
cultur
blood
bacterium
consid
etiolog
scap
grew
goodqual
bronchial
aspir
cutoff
colonyform
unit
cfu
bal
cutoff
cfu
urin
antigen
test
pneumonia
l
pneumonia
posit
presenc
immunoglobulin
antibodi
andor
signific
increas
least
rise
immunoglobulin
g
antibodi
level
pair
serum
sampl
consid
signifi
acut
pneumonia
c
pneumonia
infect
median
interv
pair
serum
sampl
day
three
set
nasopharyng
np
swab
collect
detect
respiratori
virus
np
swab
obtain
use
copan
brush
swab
store
steril
sampl
tube
deepfrozen
analysi
first
icu
day
bal
respiratori
viral
diagnost
perform
whenev
possibl
bal
sampl
sent
hospit
microbiolog
patholog
laboratori
diagnost
accord
normal
practic
two
sampl
bal
fluid
also
store
pcr
analysi
later
date
bal
studi
possibl
normal
bronchoscopi
perform
bronchial
suction
aspir
sampl
collect
via
intub
tube
viru
detect
np
swab
sampl
bal
fluid
bronchial
suction
aspir
sent
analysi
respiratori
virus
viru
diagnost
laboratori
univers
turku
nasopharyng
swab
bronchial
aspir
bal
sampl
analyz
pcr
multiplex
pcr
test
kit
anyplex
seegen
south
korea
use
detect
adenoviru
influenza
b
virus
parainfluenza
viru
type
rhinoviru
respiratori
syncyti
virus
b
bocaviru
coronavirus
metapneumoviru
enterovirus
addit
inhous
pcr
test
use
detect
enterovirus
rhinovirus
previous
describ
virus
consid
probabl
caus
scap
detect
np
swab
pcr
definit
diagnosi
viral
caus
scap
requir
posit
pcr
result
lower
respiratori
tract
specimen
etiolog
type
scap
classifi
follow
pure
bacteri
infect
etiolog
examin
reveal
bacteria
probabl
pure
viral
infect
viral
find
recov
mix
bacterialvir
infect
etiolog
examin
yield
bacteri
viral
find
also
etiolog
group
consist
patient
bacteri
viral
examin
remain
neg
continu
variabl
median
percentil
use
count
use
categor
variabl
probabl
pure
viral
group
exclud
statist
comparison
due
small
number
case
comparison
continu
variabl
pure
bacteri
mix
bacterialvir
group
analyz
use
student
ttest
mannwhitney
u
test
categor
variabl
analyz
use
fisher
exact
test
twotail
p
valu
calcul
analys
perform
use
spss
window
version
ibm
spss
armonk
new
york
total
scap
patient
mechan
ventil
applic
studi
patient
exclud
follow
reason
life
expect
hour
due
diseas
sever
n
long
hospit
stay
transfer
icu
n
studi
personnel
avail
n
exclus
final
studi
group
consist
scap
patient
follow
sampl
collect
test
perform
examin
scap
patient
blood
cultur
urin
pneumococc
legionella
antigen
test
np
swab
admiss
pair
serum
sampl
pneumonia
c
pneumonia
antibodi
detect
lower
tracheal
specimen
avail
patient
includ
fiberopt
bronchoscop
bal
specimen
patient
bronchial
aspir
obtain
intub
tube
patient
etiolog
scap
defin
case
pure
bacteri
etiolog
diagnos
patient
microbiolog
find
among
pure
bacteri
bacterialvir
group
shown
tabl
streptococcu
pneumonia
commonli
identifi
bacterium
found
case
pure
bacteri
bacterialvir
infect
pneumococcu
sole
pathogen
case
patient
pneumonia
cultur
patient
blood
patient
bronchial
aspir
pneumococc
antigen
posit
urin
case
acut
pneumonia
infect
observ
case
etiolog
microb
case
wherea
present
copathogen
remain
patient
tabl
identifi
bacteria
suscept
antibiot
use
treatment
pneumonia
case
c
pneumonia
l
pneumophila
p
jirovecii
mycobacterium
tuberculosi
two
patient
pure
bacteri
group
patient
probabl
pure
viral
group
develop
empyema
later
hospit
stay
viral
etiolog
scap
diagnos
patient
virus
identifi
caus
scap
case
identifi
togeth
bacteria
case
tabl
twentysix
virus
detect
among
scap
patient
tabl
virus
identifi
detect
bronchial
specimen
detect
np
swab
np
bronchial
pcr
posit
case
common
viru
rhinoviru
identifi
case
tabl
rhinoviru
detect
time
bronchial
specimen
time
nasopharyng
swab
commerci
pcr
test
miss
patient
posit
rhinoviru
find
identifi
inhous
pcr
test
adenoviru
found
case
viru
find
follow
case
coronaviru
case
enteroviru
case
influenza
respiratori
syncyti
viru
parainfluenza
two
patient
posit
viral
test
five
patient
suffer
probabl
pure
viral
scap
tabl
mix
bacterialvir
group
common
combin
pneumonia
rhinoviru
occur
case
tabl
depict
patient
characterist
occurr
organ
failur
icu
treatment
group
pure
bacteri
infect
bacterialvir
infect
compar
hospit
admiss
antibiot
therapi
alreadi
initi
patient
bacteri
group
bacterialvir
group
viral
comparison
laboratori
find
outcom
data
group
pure
bacteri
mix
bacterialvir
infect
probabl
pure
viral
etiolog
present
tabl
admiss
patient
fulfil
idsaat
major
criteria
tabl
patient
requir
mechan
ventil
remain
patient
septic
shock
requir
vasopressor
condit
later
deterior
also
requir
mechan
ventil
accord
median
valu
scap
patient
etiolog
group
belong
psi
sever
group
iv
median
score
group
vari
tabl
signific
differ
group
tabl
tabl
also
show
pure
bacteria
group
highest
apach
ii
score
admiss
p
median
icu
stay
differ
group
tabl
wherea
hospit
stay
longest
among
bacteri
group
p
tabl
almost
half
scap
patient
studi
exhibit
evid
viral
etiolog
base
multiplex
realtim
pcr
test
eighti
percent
viral
find
detect
sampl
obtain
lower
respiratori
tract
underscor
etiolog
import
viral
find
clinic
characterist
outcom
similar
pure
bacteri
mix
bacterialvir
infect
group
howev
apach
ii
score
highest
admiss
hospit
stay
longest
bacteri
group
major
strength
studi
prospect
studi
one
investig
j
k
systemat
treat
patient
allow
high
success
rate
etiolog
examin
use
bronchoscop
largescal
microbiolog
method
includ
multipl
viral
pcr
techniqu
etiolog
scap
defin
case
one
highest
rate
diagnosi
report
thu
far
onethird
scap
patient
antibiot
etiolog
examin
perform
therefor
posit
blood
cultur
less
often
patient
without
previou
antibiot
icu
mortal
mortal
hospit
mortal
valu
present
median
percentil
abbrevi
crp
creactiv
protein
icu
intens
care
unit
pct
procalcitonin
wbc
white
blood
cell
comparison
bacterialonli
infect
bacterialvir
infect
group
potenti
weak
studi
perform
singl
center
may
limit
generaliz
result
center
furthermor
find
studi
repres
situat
encount
intub
scap
patient
whose
icu
stay
hour
unfortun
sampl
could
obtain
case
scap
patient
due
unavail
studi
personnel
final
rel
small
sampl
size
may
affect
statist
analysi
exampl
multivari
logist
regress
analys
could
calcul
despit
limit
number
studi
patient
largest
studi
bronchoscop
pcr
sampl
mechan
ventil
scap
patient
thu
far
report
literatur
viral
etiolog
scap
spars
recent
korean
singlecent
scap
studi
virus
detect
scap
patient
multicent
scap
studi
conduct
unit
state
proport
virus
detect
vari
may
juli
octob
virus
identifi
patient
present
scap
seri
pcr
perform
np
swab
virus
detect
scap
patient
wherea
hospit
swedish
cap
patient
patient
us
multicent
scap
studi
demonstr
viral
infect
use
np
swab
also
critic
may
repres
actual
lower
respiratori
find
may
case
scap
patient
present
studi
viru
detect
use
np
swab
present
investig
recoveri
viral
pcr
higher
lower
respiratori
tract
specimen
np
swab
rhinoviru
discov
scap
patient
higher
previous
report
studi
rhinoviru
find
detect
lower
respiratori
tract
sampl
import
lower
respiratori
tract
sampl
viral
detect
also
seen
influenza
pandem
pcr
method
select
may
also
influenc
result
commerci
pcr
test
would
miss
rhinoviru
scap
case
compar
inhous
test
taken
togeth
systemat
use
invas
respiratori
sampl
method
custom
inhous
viru
test
may
explain
higher
total
yield
virus
present
seri
compar
earlier
public
involv
hospit
cap
scap
patient
viral
analysi
bal
fluid
particularli
use
immunocompromis
patient
seri
presenc
virus
respiratori
sampl
scap
patient
demonstr
almost
half
case
result
may
implic
regard
point
transmiss
respiratori
virus
icu
especi
among
noninvas
ventil
scap
patient
larger
studi
need
demonstr
prognost
import
possibl
transmiss
respiratori
viral
infect
critic
care
environ
gener
polymicrobi
infect
cap
consid
caus
sever
inflamm
clinic
diseas
singl
microbi
infect
present
seri
mix
bacterialvir
infect
group
seem
need
longer
period
noradrenalin
infus
pure
bacteri
infect
group
experiment
studi
shown
case
respiratori
bacterialvir
coinfect
erad
bacteria
prevent
fatal
outcom
result
influenza
infect
hand
present
studi
recent
korean
scap
studi
presenc
virus
appear
affect
outcom
neutral
find
shown
among
cap
patient
well
find
may
suggest
viral
coinfect
context
scap
necessarili
prognost
import
small
number
patient
studi
prevent
robust
conclus
howev
consid
import
viral
infect
outcom
seri
patient
bacteri
scap
sever
ill
admiss
base
apach
ii
score
longest
hospit
stay
compar
mix
bacterialvir
group
durat
symptom
differ
etiolog
group
howev
suggest
virus
may
essenti
role
pathogenesi
scap
present
studi
crp
pct
valu
seem
higher
mix
bacterialvir
group
compar
pure
bacteri
scap
patient
whether
differ
caus
intens
inflamm
mix
bacterialvir
group
remain
open
question
lowest
pct
level
found
group
probabl
pure
viral
infect
patient
howev
much
higher
pct
concentr
thu
far
suggest
level
differenti
bacteri
viral
infect
furthermor
patient
seri
probabl
pure
viral
infect
group
actual
receiv
antibiot
respiratori
sampl
moreov
pcr
test
common
bacteri
caus
cap
pneumonia
would
avail
least
probabl
pure
viral
infect
may
prove
bacterialvir
infect
present
studi
demonstr
achiev
higher
yield
viral
diagnos
scap
patient
highli
qualifi
multiplex
pcr
method
invas
sampl
need
wider
use
approach
care
consid
antivir
agent
treatment
common
respiratori
virus
readili
avail
antivir
agent
current
avail
influenza
viru
adenoviru
pcr
result
studi
popul
would
avail
patient
may
use
cidofovir
treatment
major
find
studi
follow
etiolog
scap
diagnos
studi
patient
respiratori
virus
detect
viral
etiolog
impact
diseas
sever
clinic
outcom
conclus
viral
etiolog
common
scap
report
thu
far
recoveri
virus
patient
scap
influenc
avail
modern
multiplex
pcr
techniqu
abil
use
invas
method
obtain
lower
respiratori
specimen
presenc
viral
etiolog
howev
appear
affect
outcom
scap
patient
